121 related articles for article (PubMed ID: 28433985)
41. 5-Fluorouracil-induced acute dilated cardiomyopathy in a pediatric patient.
Radhakrishnan V; Bakhshi S
J Pediatr Hematol Oncol; 2011 May; 33(4):323. PubMed ID: 21423045
[No Abstract] [Full Text] [Related]
42. DPYD variants to predict 5-FU toxicity: the ultimate proof.
Innocenti F
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25381394
[No Abstract] [Full Text] [Related]
43. Tegafur-induced hyperpigmentation of the tongue.
Kim HS; Park YM; Kim HO; Lee JY
J Dermatol; 2010 Oct; 37(10):937-8. PubMed ID: 20860752
[No Abstract] [Full Text] [Related]
44. Acute coronary syndrome secondary to fluorouracil infusion.
Lu JI; Carhart RL; Graziano SL; Gajra A
J Clin Oncol; 2006 Jun; 24(18):2959-60. PubMed ID: 16782933
[No Abstract] [Full Text] [Related]
45. Fluorouracil-Induced Hyperpigmentation.
Schaefer JK; Ramnath N
N Engl J Med; 2020 Jan; 382(4):e6. PubMed ID: 31971682
[No Abstract] [Full Text] [Related]
46. [Cardioxan as a cardioprotector in antineoplastic chemotherapy].
Lichinitser MP; Vyshinskaia GV; Min'kov ED; Nakhalova TA; Odzharova AA; Garin AM
Klin Med (Mosk); 1996; 74(5):65-7. PubMed ID: 8999195
[No Abstract] [Full Text] [Related]
47. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.
Steele JC; Triantafyllou A; Rajlawat BP; Field EA
Clin Exp Dermatol; 2012 Jun; 37(4):432-3. PubMed ID: 22420895
[No Abstract] [Full Text] [Related]
48. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
49. [Adjuvant chemotherapy in older women with breast cancer. CALGB Study (The Cancer and Leukemia Group B Study)].
Mallmann P; Nitschmann S
Internist (Berl); 2010 Jul; 51(7):923-4. PubMed ID: 20544172
[No Abstract] [Full Text] [Related]
50. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs.
Reyes-Habito CM; Roh EK
J Am Acad Dermatol; 2014 Aug; 71(2):203.e1-203.e12; quiz 215-6. PubMed ID: 25037800
[TBL] [Abstract][Full Text] [Related]
51. [Subacute cutaneous lupus erythematosus induced by 5-fluorouracil].
Baggio R; Chavel P; Tisseau L; Darrieux L; Safa G
Presse Med; 2017 Sep; 46(9):876-879. PubMed ID: 28666566
[No Abstract] [Full Text] [Related]
52. [Bradyarrhythmia after chemotherapy with 5-fluorouracil].
Schneider M; Schneider G
Dtsch Med Wochenschr; 2002 May; 127(22):1192. PubMed ID: 12035115
[No Abstract] [Full Text] [Related]
53. [Vasospasm following chemotherapy with 5-fluorouracil].
Martínez Sellés M; Pérez Castellano N; Bueno Zamora H; González Torrecilla E; Abeytua Jiménez M; Delcán Domínguez JL
An Med Interna; 2001 Feb; 18(2):112-3. PubMed ID: 11321998
[No Abstract] [Full Text] [Related]
54. Capecitabine-induced eruptive acral hyperpigmentation: Clinical and dermoscopic evaluation of two cases.
Peccerillo F; Pampena R; Giannetti L; Pellacani G; Longo C
Dermatol Ther; 2019 May; 32(3):e12853. PubMed ID: 30748073
[No Abstract] [Full Text] [Related]
55. Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
Masson Regnault M; Gadaud N; Boulinguez S; Tournier E; Lamant L; Gladieff L; Roche H; Guenounou S; Recher C; Sibaud V
Dermatology; 2015; 231(4):312-8. PubMed ID: 26422424
[TBL] [Abstract][Full Text] [Related]
56. Colonic methane production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil chemotherapy for colorectal cancer.
Holma R; Korpela R; Sairanen U; Blom M; Rautio M; Poussa T; Saxelin M; Osterlund P
J Clin Gastroenterol; 2013 Jan; 47(1):45-51. PubMed ID: 23090038
[TBL] [Abstract][Full Text] [Related]
57. Minocycline-induced oral hyperpigmentation.
Eisen D
Lancet; 1997 Feb; 349(9049):400. PubMed ID: 9033473
[No Abstract] [Full Text] [Related]
58. Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin.
van Kuilenburg AB; Klumpen HJ; Westermann AM; Zoetekouw L; Van Lenthe H; Bakker PJ; Richel DJ; Guchelaar HJ
Eur J Cancer; 2007 Jan; 43(2):459-65. PubMed ID: 17097873
[TBL] [Abstract][Full Text] [Related]
59. Oral status in patients receiving 5-fluorouracil for colorectal cancer.
Djuric M; Cakic S; Hadzi-Mihailovic M; Petrovic D; Jankovic L
J BUON; 2010; 15(3):475-9. PubMed ID: 20941813
[TBL] [Abstract][Full Text] [Related]
60. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
